Page last updated: 2024-08-26

catalpol and Osteogenic Sarcoma

catalpol has been researched along with Osteogenic Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Wang, L; Xue, GB	1

Other Studies

1 other study(ies) available for catalpol and Osteogenic Sarcoma

Article	Year
Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis. Biochemical and biophysical research communications, 2018, 01-01, Volume: 495, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Humans; Iridoid Glucosides; Male; Mice; Mice, Inbred BALB C; Osteosarcoma; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2018

Article

Year

Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis.

Biochemical and biophysical research communications, 2018, 01-01, Volume: 495, Issue:1

Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Humans; Iridoid Glucosides; Male; Mice; Mice, Inbred BALB C; Osteosarcoma; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2018